Was it simply a fluke that he kept treating strikingly young patients? Or was his practice one tiny data point in a larger trend? He found his answer after sifting through national health data: ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

This lesion is characterized by cellular ... indicate premalignant disease (low-grade prostatic intraepithelial neoplasia, atrophy, malignancy-associated changes, and atypical adenomatous ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

"Nearly all premalignant cervical lesions and cervical cancers ... HPV16-positive high-grade cervical intraepithelial neoplasia: a Phase II trial, Clinical Cancer Research (2025).

The participating centers were certified oncology centers according to the national audit program of the German Cancer Society. The first follow-up visit was to occur 6 months after the start of ...

of whom 18.2% had HPV-negative results and negative intraepithelial lesion or malignancy (NILM) cytologic findings and 25.5% had abnormal results, reported Jasmin Tiro, PhD, of the University of ...